Drug Manufacturers - Specialty & Generic | Healthcare
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, and anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology, cardiovascular, pediatrics, neurology, anti-dengue, and dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.
Market Cap
35947515904
Current Price
2173.5
52 Week Range
1515.0 - 2974.95
Previous Close
2178.6
Open
2189.4
Sector
Healthcare
Address
RPG House, 463, Dr. Annie Besant Road Worli, Mumbai, 400030, India
Phone
+91-22697-57100
Fax
+91-22249-70127
Website
https://www.rpglifesciences.com
Day Low
2166.2
Day High
2190.5
Dividend Yield
0.74
PE Ratio
19.409716
Earnings Per Share
111.98
Beta
-0.267
EBITDA
1596499968
Book Value
320.805
EPS
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Ashok Nair | MD & Additional Director | - | - |
Mr. Vishal Shah | Chief Financial Officer | - | - |
Mr. Rajesh Shirambekar | Head of Legal, Compliance Officer & Company Secretary | - | - |
Mr. Samir Rane | Vice President of Sales & Marketing (Main Division) | - | - |
Ms. Sheetal Gaba | Chief Human Resources Officer | - | - |
Mr. Kartick C. Patra | Head of API Operations & Procurement | - | - |
Mr. Rajesh Chopra | Site Head of International Formulation | - | - |
Mr. Milind Gujar | Chief Quality Officer | - | - |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.